Skip to content
TrustList
M. H. Carnegie & Co. logo
Venture capital firm

M. H. Carnegie & Co.

M. H. Carnegie & Co. is an Australian alternative asset manager investing across several asset classes

M. H. Carnegie & Co. cover

TrustList summary

M. H. Carnegie & Co. is an alternative asset manager based in Moore Park, New South Wales, Australia, managing funds across eight platforms since its establishment in 2011. It invests across venture capital, private equity, real estate and debt, describing its approach as building platform businesses led by figures with sector knowledge and networks who bring that knowledge alongside the firm's own team. The firm says it aligns its own capital alongside that of its investors, taking its override only after investors receive an agreed base return, and frames its role as investment evaluation rather than asset allocation, which it sees as the investor's own task. M. H. Carnegie & Co. holds an AFSL and takes enquiries from investors as well as philanthropic and internship-related contacts.

Summary written by TrustList from the business's own published information, Sep 2026.

Ask TrustList to introduce you to M. H. Carnegie & Co.

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of M. H. Carnegie & Co.

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about M. H. Carnegie & Co..

M. H. Carnegie & Co. alternatives

Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Open-source blockchain with its own digital currency, digital assets, smart contracts and secure authentication

Pharmaceutical group's partnering and venture investment arm working with outside biotech innovators

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Africa-focused investor that funds and mentors entrepreneurs, backed by the Chandaria Group of Companies